Galvanize Therapeutics
Pulsed electric field medical devices for surgical soft-tissue ablation.
$130MSeries D
ParticipantActivity from announced rounds
Pulsed electric field medical devices for surgical soft-tissue ablation.
AdvanCell develops targeted alpha radiopharmaceuticals for cancer using Lead-212, with integrated isotope supply and manufacturing.
Develops medical devices for kidney stone treatment and removal
Develops treatments for patients suffering from thromboembolic disease